-+ 0.00%
-+ 0.00%
-+ 0.00%

Edwards Lifesciences Narrows FY2026 Sales Guidance from $6.600B-$6.900B to $6.766B vs $6.767B Est

Benzinga·11/04/2026 21:20:32
Listen to the news
Edwards Lifesciences (NYSE:EW) narrows FY2026 sales outlook from $6.600 billion-$6.900 billion to $6.766 billion vs $6.767 billion estimate.